HomeCompareHKMPF vs VICI

HKMPF vs VICI: Dividend Comparison 2026

HKMPF yields 4.85% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HKMPF wins by $301.59M in total portfolio value
10 years
HKMPF
HKMPF
● Live price
4.85%
Share price
$17.30
Annual div
$0.84
5Y div CAGR
85.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$302.56M
Annual income
$279,218,818.50
Full HKMPF calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — HKMPF vs VICI

📍 HKMPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHKMPFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HKMPF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HKMPF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HKMPF
Annual income on $10K today (after 15% tax)
$412.45/yr
After 10yr DRIP, annual income (after tax)
$237,335,995.73/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, HKMPF beats the other by $236,819,726.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HKMPF + VICI for your $10,000?

HKMPF: 50%VICI: 50%
100% VICI50/50100% HKMPF
Portfolio after 10yr
$151.76M
Annual income
$139,913,097.31/yr
Blended yield
92.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

HKMPF
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
3.5
Piotroski
7/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HKMPF buys
0
VICI buys
0
No recent congressional trades found for HKMPF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHKMPFVICI
Forward yield4.85%6.52%
Annual dividend / share$0.84$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR85.6%44.3%
Portfolio after 10y$302.56M$966.2K
Annual income after 10y$279,218,818.50$607,376.13
Total dividends collected$300.79M$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: HKMPF vs VICI ($10,000, DRIP)

YearHKMPF PortfolioHKMPF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$11,601$900.60$11,361$941.49+$240.00HKMPF
2$14,225$1,812.21$13,320$1,481.32+$905.00HKMPF
3$19,075$3,854.51$16,284$2,405.01+$2.8KHKMPF
4$29,376$8,965.67$21,040$4,071.78+$8.3KHKMPF
5$55,382$23,949.87$29,209$7,285.49+$26.2KHKMPF
6$137,579$78,320.34$44,443$14,006.51+$93.1KHKMPF
7$484,693$337,482.73$75,822$29,512.55+$408.9KHKMPF
8$2,580,955$2,062,333.89$148,733$69,726.75+$2.43MHKMPF
9$21,810,404$19,048,782.00$344,394$189,413.75+$21.47MHKMPF
10$302,555,951$279,218,818.50$966,234$607,376.13+$301.59MHKMPF

HKMPF vs VICI: Complete Analysis 2026

HKMPFStock

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.

Full HKMPF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this HKMPF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HKMPF vs SCHDHKMPF vs JEPIHKMPF vs OHKMPF vs KOHKMPF vs MAINHKMPF vs NNNHKMPF vs EPRTHKMPF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.